Last reviewed · How we verify

Nicotinamide treatment — Competitive Intelligence Brief

Nicotinamide treatment (Nicotinamide treatment) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B3 / NAD+ precursor.

phase 3 Vitamin B3 / NAD+ precursor NAD+ biosynthesis pathway Small molecule Live · refreshed every 30 min

Target snapshot

Nicotinamide treatment (Nicotinamide treatment) — Assistance Publique - Hôpitaux de Paris. Nicotinamide replenishes NAD+ cofactor pools to support cellular energy metabolism and DNA repair pathways.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Nicotinamide treatment TARGET Nicotinamide treatment Assistance Publique - Hôpitaux de Paris phase 3 Vitamin B3 / NAD+ precursor NAD+ biosynthesis pathway

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B3 / NAD+ precursor class)

  1. Assistance Publique - Hôpitaux de Paris · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Nicotinamide treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/nicotinamide-treatment. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: